Health
Biotechnology
Biopharmaceutical

Amarin

38,222

$5.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.24 (+4.82%) Today
-$0.12 (-2.30%) As of 4:54 AM EDT after-hours

Why Robinhood?

You can buy or sell Amarin and other stocks, options, ETFs, and crypto commission-free!

About AMRN

Amarin Corporation plc, also called Amarin, is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Read More It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

CEO
John F. Thero
Employees
965
Headquarters
Dublin, Dublin
Founded
1989
Market Cap
1.88B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
36.29M
High Today
$5.75
Low Today
$5.06
Open Price
$5.30
Volume
58.58M
52 Week High
$26.12
52 Week Low
$3.95

Collections

Health
Biotechnology
Biopharmaceutical
Pharmaceutical
Medical
Technology
Therapy
Europe

AMRN News

BenzingaMar 31

Amarin Analysts React To Vascepa Patent Loss, See Small Chance Of Overturning Judgment

Amarin Corporation plc (NASDAQ: AMRN) shares were tumbling Tuesday in reaction to a negative verdict issued by a U.S. District Court regarding generic versions
9,862
MarketWatchMar 31

Amarin's stock plummets on heavy volume after court rules in favor of makers of generic Vascepa

Shares of Amarin Corp. PLC AMRN, +2.57% took a 69% dive on heavy volume in premarket trading Tuesday, after drug maker announced a disappointing court ruling in
8,876
CNBCMar 31

Stocks making the biggest moves in the premarket: Conagra, Carnival, RH, Visa & more

Take a look at some of the biggest movers in the premarket: Conagra (CAG) – The food producer missed estimates by 2 cents a share, with fiscal third-quarter pr
1,126

AMRN Earnings

-$0.11
-$0.07
-$0.02
$0.02
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 29, After Hours

People Also Bought

Viking Therapeutics

51,331

$4.55

+4.60%

Viking Therapeutics

51,331

$4.55

+4.60%

Matinas BioPharma

13,041

$0.55

-1.04%

Acasti Pharma

7,773

$0.345

+4.55%

Geron

31,169

$1.02

-4.67%

You May Also Like

COWNL
AMKBY
VYMI
HYUP
OPY
ACWX
WRB-B
MTUM
TRNS
GXTG

More AMRN News

BenzingaMar 31

Amarin Shares Drop 67% As Court Invalidates Its Heart Drug Patent For Vascepa

The shares of Amarin Corporation plc (NASDAQ: AMRN) tanked in the after-hours session on Monday as the court ruled against its patent for heart treatment drug V
2,224
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy AMRN

Market Price$5.10
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Amarin stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up